A Phase I, Randomized, Placebo Controlled, Multiple Dose Study To Determine Safety, Tolerability And Pharmacokinetics Of PF-04455242 In Healthy Adult Subjects.

Trial Profile

A Phase I, Randomized, Placebo Controlled, Multiple Dose Study To Determine Safety, Tolerability And Pharmacokinetics Of PF-04455242 In Healthy Adult Subjects.

Completed
Phase of Trial: Phase I

Latest Information Update: 08 Jan 2010

At a glance

  • Drugs PF 4455242 (Primary)
  • Indications Bipolar disorders
  • Focus Adverse reactions; Pharmacokinetics
  • Sponsors Pfizer
  • Most Recent Events

    • 08 Jan 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 10 Oct 2009 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
    • 19 Aug 2009 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top